SPINK1 and cancer: Thus, restoring miR‐338‐5p and miR‐421 expression using either epigenetic drugs or synthetic mimics could abrogate SPINK1‐mediated oncogenesis by targeting multiple oncogenic pathways and eliciting anti‐cancer pleiotropic effects.